Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Why Transition of Care Planning is a Game Changer for Adjusters
Effective transition of care planning helps claims adjusters manage complex workers’ compensation cases by preventing setbacks, reducing readmissions, and supporting faster, safer recovery for injured employees.
Trump executive order presents challenges for workers’ comp, auto insurers
Discover how Enlyte experts Lisa Robinson and Michele Hibbert analyze the recent health care executive order's impact on workers’ comp and auto insurers.
Accelerating Recovery and Return to Work: The Case for Case Management
Explore how proactive case management accelerates recovery and return-to-work outcomes by addressing physical, emotional, and workplace barriers—leading to better clinical results and lower claim costs.
Turning Regulatory Obstacles into Strategy Advantages Using Informed Decision-Making in Workers’ Comp & Auto Casualty
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in Part 1 of our series, this article explores how advanced bill review technologies can help position payers to effectively navigate current changes and set themselves up for enhanced savings in the long term.
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Discover how U.S. trade tariffs and proposed Medicaid cuts could reshape workers’ comp costs and care access. Dave Torrence outlines key risks and strategies in WorkCompWire’s "Leaders Speak" article.
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
Discover how vocational case management can reduce claim costs and improve return-to-work outcomes. Essential guide for claims professionals seeking efficient claim resolution.